+7 (499) 340 10 14

Ministry of Industry and Trade does not Support FAS Initiative

Suggestion of the Head of FAS Igor Artemiev to accept results of clinical studies of drugs approved by the FDA (USA) and EMA (EU) for marketing authorization of international drugs, did not find support of the Ministry of Industry and Trade. It was remarked in the agency that discontinuation of obligatory clinical trials of drugs approved in the US and EU will create additional preferences for international companies in the Russian pharma market. It contradicts to state policy in the field of development of local pharma industry.

LABMGMU LABMGMU +7 (499) 340 10 14 info@labmgmu.ru 119435, Moscow, Malaya Pirogovskay str. 13-1, floor 4